Acta Med. 2025, 68: 95-100

https://doi.org/10.14712/18059694.2025.27

Assessment of Urine Kidney Injury Molecule-1 as an Early Biomarker for Nephropathy in Sickle Cell Anaemia Patients

Akeem Olayinka Busaria,b,c, Shola Lois Jolayemia, Muhammad Bello Ahmadd, Renata Trentin Perdomob

aDepartment of Medical Laboratory Science, Kwara State University, Malete, Nigeria
bLaboratório de Biologia Molecular e Cultura Celular, Laboratório de Fluidos Biológicos e Citologia Clínica, Farmácia-FACFAN, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil
cLaboratório de Biologia Molecular e Cultura Celular, Laboratório de Fluidos Biológicos e Citologia Clínica, Instituto Biosciência/Farmácia-INBIO/FACFAN, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil
dDepartment of Medical Laboratory Science, Bayero University, Kano, Nigeria

Received June 29, 2025
Accepted September 1, 2025

References

1. Simoneaux R. Whole Genome Sequencing of Pediatric Sickle Cell Disease Patients. Oncol Times. 2019 Feb 5; 41(3): 11–12.
2. Venugopal A, Chandran M, Eruppakotte N, Kizhakkillach S, Breezevilla SC, Vellingiri B. Monogenic diseases in India. Mutat Res Rev Mutat Res. 2018 Apr–Jun; 776: 23–31. <https://doi.org/10.1016/j.mrrev.2018.03.003>
3. Sarat CNF, Ferraz MB, Ferreira Junior MA, et al. Prevalence of sickle cell disease in adults with delayed diagnosis. Acta Paul Enferm. 2019; 32(2): 202–9. <https://doi.org/10.1590/1982-0194201900028>
4. Egesa WI, Nakalema G, Waibi WM, et al. Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond. Int J Pediatr. 2022 Oct 8; 2022: 3885979. <https://doi.org/10.1155/2022/3885979> <PubMed>
5. Uçucu S, Karabıyık T, Azik F. Difficulties in the diagnosis of HbS/beta thalassemia: Really a mild disease? J Med Biochem. 2022 Feb 2; 41(1): 32–9. <https://doi.org/10.5937/jomb0-30420> <PubMed>
6. Brandow AM, Liem RI. Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol. 2022 Mar 3; 15(1): 20. <https://doi.org/10.1186/s13045-022-01237-z> <PubMed>
7. Nnaji UM, Ogoke CC, Okafor HU, Achigbu KI. Sickle Cell Nephropathy and Associated Factors among Asymptomatic Children with Sickle Cell Anaemia. Int J Pediatr. 2020 Aug 14; 2020: 1286432. <https://doi.org/10.1155/2020/1286432> <PubMed>
8. Piccin A, Murphy C, Eakins E. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment. Eur J Haematol. 2019 Apr; 102(4): 319–30. <https://doi.org/10.1111/ejh.13212>
9. Chinegwundoh FI, Smith S, Anie KA. Treatments for priapism in boys and men with sickle cell disease. Cochrane Database Syst Rev. 2020 Apr 6; 4(4): CD004198.
10. Adebayo OC, Van den Heuvel LP, Olowu WA, Levtchenko EN, Labarque V. Sickle cell nephropathy: insights into the pediatric population. Pediatr Nephrol. 2022 Jun; 37(6): 1231–43. <https://doi.org/10.1007/s00467-021-05126-4>
11. World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001; 79(4): 373–4.
12. Résimont G, Piéroni L, Bigot-Corbel E, Cavalier E, Delanaye P. Urinary strips for protein assays: easy to do but difficult to interpret! J Nephrol. 2021 Apr; 34(2): 411–32. <https://doi.org/10.1007/s40620-020-00735-y>
13. Westermeier R. Electrophoresis in practice: a guide to methods and applications of DNA and protein separations. John Wiley & Sons; 2016 May 16.
14. Tarim EA, Tekin HC. Colorimetric detection of serum creatinine on a miniaturized platform using hue-saturation-value space analysis. Sci Rep. 2024 Aug 21; 14(1): 19441. <https://doi.org/10.1038/s41598-024-69719-3> <PubMed>
15. Lu S, Robyak K, Zhu Y. The CKD-EPI 2021 Equation and Other Creatinine-Based Race-Independent eGFR Equations in Chronic Kidney Disease Diagnosis and Staging. J Appl Lab Med. 2023 Sep 7; 8(5): 952–61. <https://doi.org/10.1093/jalm/jfad047>
16. Jin Y, Shao X, Sun B, Miao C, Li Z, Shi Y. Urinary kidney injury molecule‑1 as an early diagnostic biomarker of obstructive acute kidney injury and development of a rapid detection method. Mol Med Rep. 2017 Mar; 15(3): 1229–35. <https://doi.org/10.3892/mmr.2017.6103> <PubMed>
17. Ataga KI, Saraf SL, Derebail VK. The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol. 2022 Jun; 18(6): 361–77. <https://doi.org/10.1038/s41581-022-00540-9> <PubMed>
18. Elenga N, Yassin MA. Real-world observational study on the long-term effect of L-glutamine treatment on renal parameters of adult and pediatric patients with sickle cell disease. Front Med (Lausanne). 2023 Dec 6; 10: 1243870. <https://doi.org/10.3389/fmed.2023.1243870> <PubMed>
19. Olaniran KO, Eneanya ND, Nigwekar SU, et al. Sickle Cell Nephropathy in the Pediatric Population. Blood Purif. 2019; 47(1–3): 205–13. <https://doi.org/10.1159/000494581>
20. Ghadrdan E, Ebrahimpour S, Sadighi S, Chaibakhsh S, Jahangard-Rafsanjani Z. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin. J Oncol Pharm Pract. 2020 Oct; 26(7): 1643–9. <https://doi.org/10.1177/1078155220901756>
21. Martins PRJ, De Vito FB, Resende GAD, Kerbauy J, Pereira GA, Moraes-Souza H, Figueiredo MS, Verreschi IT. Male sickle cell patients, compensated transpubertal hypogonadism and normal final growth. Clin Endocrinol (Oxf). 2019 Nov; 91(5): 676–82. <https://doi.org/10.1111/cen.14075>
22. Doshi RN, Jain A, Saiyad SS, Sayeed MS. Growth Delays and Developmental Challenges in Children with Sickle Cell Disease. Int J Pharm Clin Res. 2024 Oct 31; 16(10): 62–6.
23. Tehseen S, Joiner CH, Lane PA, Yee ME. Changes in urine albumin to creatinine ratio with the initiation of hydroxyurea therapy among children and adolescents with sickle cell disease. Pediatr Blood Cancer. 2017 Dec; 64(12): e26665. <https://doi.org/10.1002/pbc.26665>
24. Afangbedji N, Jerebtsova M. Glomerular filtration rate abnormalities in sickle cell disease. Front Med (Lausanne). 2022 Oct 21; 9: 1029224. <https://doi.org/10.3389/fmed.2022.1029224> <PubMed>
25. Belisário AR, da Silva AA, Silva CV, et al. Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients. Biomark Med. 2019 Aug; 13(11): 967–87. <https://doi.org/10.2217/bmm-2019-0105>
26. Laurentino MR, Parente Filho SLA, Parente LLC, da Silva Júnior GB, Daher EF, Lemes RPG. Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview. Ann Hematol. 2019 Dec; 98(12): 2653–60. <https://doi.org/10.1007/s00277-019-03813-9>
27. Neto FD, Santos MJ, Adôrno EV, Ferreira JR, Gonçalves MS, Barbosa CG. Early Urinary Biomarkers of Renal Damage in Sickle Cell Disease Patients. Hematol Transfus Cell Ther. 2024 Oct 1; 46: S72. <https://doi.org/10.1016/j.htct.2024.09.120>
28. Niss O, Lane A, Asnani MR, et al. Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study. Blood Adv. 2020 Apr 14; 4(7): 1501–11. <https://doi.org/10.1182/bloodadvances.2019001378> <PubMed>
29. Kasztan M, Fox BM, Lebensburger JD, et al. Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice. Blood Adv. 2019 May 14; 3(9): 1460–75. <https://doi.org/10.1182/bloodadvances.2018028878> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive